These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 17908691)

  • 1. Rapamycin promotes vascular smooth muscle cell differentiation through insulin receptor substrate-1/phosphatidylinositol 3-kinase/Akt2 feedback signaling.
    Martin KA; Merenick BL; Ding M; Fetalvero KM; Rzucidlo EM; Kozul CD; Brown DJ; Chiu HY; Shyu M; Drapeau BL; Wagner RJ; Powell RJ
    J Biol Chem; 2007 Dec; 282(49):36112-20. PubMed ID: 17908691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PDGF-induced vascular smooth muscle cell proliferation is associated with dysregulation of insulin receptor substrates.
    Zhao Y; Biswas SK; McNulty PH; Kozak M; Jun JY; Segar L
    Am J Physiol Cell Physiol; 2011 Jun; 300(6):C1375-85. PubMed ID: 21325637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes.
    Tremblay F; Gagnon A; Veilleux A; Sorisky A; Marette A
    Endocrinology; 2005 Mar; 146(3):1328-37. PubMed ID: 15576463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mTOR/p70 S6K1 pathway regulates vascular smooth muscle cell differentiation.
    Martin KA; Rzucidlo EM; Merenick BL; Fingar DC; Brown DJ; Wagner RJ; Powell RJ
    Am J Physiol Cell Physiol; 2004 Mar; 286(3):C507-17. PubMed ID: 14592809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic inhibition of the mTORC1/S6K1 pathway increases insulin-induced PI3K activity but inhibits Akt2 and glucose transport stimulation in 3T3-L1 adipocytes.
    Veilleux A; Houde VP; Bellmann K; Marette A
    Mol Endocrinol; 2010 Apr; 24(4):766-78. PubMed ID: 20203102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. mTOR regulates vascular smooth muscle cell differentiation from human bone marrow-derived mesenchymal progenitors.
    Hegner B; Lange M; Kusch A; Essin K; Sezer O; Schulze-Lohoff E; Luft FC; Gollasch M; Dragun D
    Arterioscler Thromb Vasc Biol; 2009 Feb; 29(2):232-8. PubMed ID: 19074484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammalian target of rapamycin inhibitors activate the AKT kinase in multiple myeloma cells by up-regulating the insulin-like growth factor receptor/insulin receptor substrate-1/phosphatidylinositol 3-kinase cascade.
    Shi Y; Yan H; Frost P; Gera J; Lichtenstein A
    Mol Cancer Ther; 2005 Oct; 4(10):1533-40. PubMed ID: 16227402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation of GATA-6 is required for vascular smooth muscle cell differentiation after mTORC1 inhibition.
    Xie Y; Jin Y; Merenick BL; Ding M; Fetalvero KM; Wagner RJ; Mai A; Gleim S; Tucker DF; Birnbaum MJ; Ballif BA; Luciano AK; Sessa WC; Rzucidlo EM; Powell RJ; Hou L; Zhao H; Hwa J; Yu J; Martin KA
    Sci Signal; 2015 May; 8(376):ra44. PubMed ID: 25969542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombin induces expression of FGF-2 via activation of PI3K-Akt-Fra-1 signaling axis leading to DNA synthesis and motility in vascular smooth muscle cells.
    Cao H; Dronadula N; Rao GN
    Am J Physiol Cell Physiol; 2006 Jan; 290(1):C172-82. PubMed ID: 16148030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AMP-activated protein kinase inhibits IGF-I signaling and protein synthesis in vascular smooth muscle cells via stimulation of insulin receptor substrate 1 S794 and tuberous sclerosis 2 S1345 phosphorylation.
    Ning J; Clemmons DR
    Mol Endocrinol; 2010 Jun; 24(6):1218-29. PubMed ID: 20363874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leptin-enhanced neointimal hyperplasia is reduced by mTOR and PI3K inhibitors.
    Shan J; Nguyen TB; Totary-Jain H; Dansky H; Marx SO; Marks AR
    Proc Natl Acad Sci U S A; 2008 Dec; 105(48):19006-11. PubMed ID: 19020099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance.
    Khamzina L; Veilleux A; Bergeron S; Marette A
    Endocrinology; 2005 Mar; 146(3):1473-81. PubMed ID: 15604215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adiponectin induces vascular smooth muscle cell differentiation via repression of mammalian target of rapamycin complex 1 and FoxO4.
    Ding M; Xie Y; Wagner RJ; Jin Y; Carrao AC; Liu LS; Guzman AK; Powell RJ; Hwa J; Rzucidlo EM; Martin KA
    Arterioscler Thromb Vasc Biol; 2011 Jun; 31(6):1403-10. PubMed ID: 21454807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unique, highly proliferative growth phenotype expressed by embryonic and neointimal smooth muscle cells is driven by constitutive Akt, mTOR, and p70S6K signaling and is actively repressed by PTEN.
    Mourani PM; Garl PJ; Wenzlau JM; Carpenter TC; Stenmark KR; Weiser-Evans MC
    Circulation; 2004 Mar; 109(10):1299-306. PubMed ID: 14993145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammalian target of rapamycin is activated in association with myometrial proliferation during pregnancy.
    Jaffer S; Shynlova O; Lye S
    Endocrinology; 2009 Oct; 150(10):4672-80. PubMed ID: 19589861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammalian target of rapamycin pathway regulates insulin signaling via subcellular redistribution of insulin receptor substrate 1 and integrates nutritional signals and metabolic signals of insulin.
    Takano A; Usui I; Haruta T; Kawahara J; Uno T; Iwata M; Kobayashi M
    Mol Cell Biol; 2001 Aug; 21(15):5050-62. PubMed ID: 11438661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opposing Actions of AKT (Protein Kinase B) Isoforms in Vascular Smooth Muscle Injury and Therapeutic Response.
    Jin Y; Xie Y; Ostriker AC; Zhang X; Liu R; Lee MY; Leslie KL; Tang W; Du J; Lee SH; Wang Y; Sessa WC; Hwa J; Yu J; Martin KA
    Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2311-2321. PubMed ID: 29025710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin-induced growth of pulmonary artery smooth muscle requires activation of phosphatidylinositol 3-kinase/serine-threonine protein kinase B/mammalian target of rapamycin/p70 ribosomal S6 kinase 1.
    Liu Y; Fanburg BL
    Am J Respir Cell Mol Biol; 2006 Feb; 34(2):182-91. PubMed ID: 16195541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of the phosphatidylinositol 3-kinase, Akt/protein kinase B, FRAP/mammalian target of rapamycin, and ribosomal S6 kinase 1 signaling pathways by thyroid-stimulating hormone (TSH) and stimulating type TSH receptor antibodies in the thyroid gland.
    Suh JM; Song JH; Kim DW; Kim H; Chung HK; Hwang JH; Kim JM; Hwang ES; Chung J; Han JH; Cho BY; Ro HK; Shong M
    J Biol Chem; 2003 Jun; 278(24):21960-71. PubMed ID: 12668683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the hexosamine pathway leads to phosphorylation of insulin receptor substrate-1 on Ser307 and Ser612 and impairs the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin insulin biosynthetic pathway in RIN pancreatic beta-cells.
    Andreozzi F; D'Alessandris C; Federici M; Laratta E; Del Guerra S; Del Prato S; Marchetti P; Lauro R; Perticone F; Sesti G
    Endocrinology; 2004 Jun; 145(6):2845-57. PubMed ID: 15001544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.